article thumbnail

Heart transplantation and biomarkers: a review about their usefulness in clinical practice

Frontiers in Cardiovascular Medicine

As a result, numerous biomarkers have been investigated in an effort to identify and prevent certain diseases sooner. These biomarkers are typically linked to complications from HTX. We also highlight the relationships between each biomarker and one or more problems, as well as their applicability in routine clinical practice.

article thumbnail

Semaglutide Reduced Inflammatory Biomarkers in HIV Patients With Lipohypertrophy

Med Page Today

(MedPage Today) -- DENVER -- People with HIV who received semaglutide (Ozempic, Wegovy) had reduced levels of several inflammatory biomarkers associated with cardiovascular disease, a randomized controlled trial showed. After 32 weeks, interleukin.

article thumbnail

A Multimodal Video-Based AI Biomarker for Aortic Stenosis Development and Progression

JAMA Cardiology

This cohort study explores whether a novel artificial intelligence (AI) video-based biomarker for aortic stenosis is associated with development and progression of aortic stenosis.

article thumbnail

Two common biomarkers can predict heart risk in asymptomatic childhood cancer survivors

Medical Xpress - Cardiology

Jude LIFE) have revealed that two common biomarkers of cardiac function and damage could better predict cardiomyopathy within five years than routine clinical evaluations in high-risk, asymptomatic childhood cancer survivors. Jude lifetime cohort study (St.

article thumbnail

Potential novel biomarkers of coronary heart disease discovered

Science Daily - Heart Disease

Researchers have identified novel protein biomarkers that are associated with the development of CHD in people with and without diabetes. Coronary heart disease is a major global health problem, especially among people with type 2 diabetes.

article thumbnail

Soluble immune-checkpoint factors: a potential immunotherapy biomarker

Journal of Clinical Investigation - Cardiology

There is unmet need for additional biomarkers to better select patients with non–small cell lung cancer (NSCLC) that are likely to benefit from immunotherapy in order to improve patient outcomes, reduce patient toxicity, and relieve the growing burden of healthcare costs.

article thumbnail

Analysis finds biomarkers that improve prediction accuracy of cardiovascular disease risk in people with type 2 diabetes

Medical Xpress - Cardiology

An international academic consortium has identified 13 biomarkers that significantly improve the ability to accurately predict cardiovascular disease risk in people with type 2 diabetes.